Cargando…
Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand
BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of metha...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738695/ https://www.ncbi.nlm.nih.gov/pubmed/31552389 http://dx.doi.org/10.1136/gpsych-2019-100088 |
_version_ | 1783450858457923584 |
---|---|
author | Mellsop, Graham Tapsell, Rees Holmes, Pragya |
author_facet | Mellsop, Graham Tapsell, Rees Holmes, Pragya |
author_sort | Mellsop, Graham |
collection | PubMed |
description | BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of methamphetamine. AIM: To compare the rates of later schizophrenia between age-matched mental health service users with initial diagnoses as alcohol abusers or illicit drug users. METHOD: From the PRIMHD comprehensive national database, all users of the mental health services over a 5-year period who received an ICD-10 presenting diagnosis of alcohol or substance use/abuse were identified. For each person identified, the database was examined for the following 3 years to determine the numbers later diagnosed with schizophrenia. RESULTS: For the initial alcohol problem people in their twenties, 1.7% were diagnosed as suffering from schizophrenia in the subsequent 3 years. For the initial drug problem people, the rate was 10.9%. Within that drug-using population, the indigenous Maori developed schizophrenia at a higher rate than did the remainder of the population. CONCLUSION: These findings in New Zealand require further research into their generalisability, context and explanation. |
format | Online Article Text |
id | pubmed-6738695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67386952019-09-24 Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand Mellsop, Graham Tapsell, Rees Holmes, Pragya Gen Psychiatr Original Research BACKGROUND: Recently, publications have hypothesised that the demonstrated increase in the incidence of schizophrenia in New Zealand is a side effect of the increased strength of available cannabis derivatives over the last 25+ years and the much more recent increase in the population’s use of methamphetamine. AIM: To compare the rates of later schizophrenia between age-matched mental health service users with initial diagnoses as alcohol abusers or illicit drug users. METHOD: From the PRIMHD comprehensive national database, all users of the mental health services over a 5-year period who received an ICD-10 presenting diagnosis of alcohol or substance use/abuse were identified. For each person identified, the database was examined for the following 3 years to determine the numbers later diagnosed with schizophrenia. RESULTS: For the initial alcohol problem people in their twenties, 1.7% were diagnosed as suffering from schizophrenia in the subsequent 3 years. For the initial drug problem people, the rate was 10.9%. Within that drug-using population, the indigenous Maori developed schizophrenia at a higher rate than did the remainder of the population. CONCLUSION: These findings in New Zealand require further research into their generalisability, context and explanation. BMJ Publishing Group 2019-09-05 /pmc/articles/PMC6738695/ /pubmed/31552389 http://dx.doi.org/10.1136/gpsych-2019-100088 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Mellsop, Graham Tapsell, Rees Holmes, Pragya Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title | Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title_full | Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title_fullStr | Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title_full_unstemmed | Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title_short | Mental health service users’ progression from illicit drug use to schizophrenia in New Zealand |
title_sort | mental health service users’ progression from illicit drug use to schizophrenia in new zealand |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738695/ https://www.ncbi.nlm.nih.gov/pubmed/31552389 http://dx.doi.org/10.1136/gpsych-2019-100088 |
work_keys_str_mv | AT mellsopgraham mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand AT tapsellrees mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand AT holmespragya mentalhealthserviceusersprogressionfromillicitdrugusetoschizophreniainnewzealand |